10 Aug PLENARY SESSION: A DEEP DIVE INTO THE FUTURE OF ADVANCED THERAPIES
Aseptic Technologies Ballroom
This session will feature leading executives in the advanced therapies space who will discuss a number of topics including the current state of the sector, future technologies and innovations, and a forecast on potential approvals. The session will also touch upon solutions for manufacturing and regulatory bottlenecks as the sector moves towards commercialization, as well as the evolution of reimbursement payment models.
Moderator:
Anshul Mangal, President, Project Farma and Precision ADVANCE – Confirmed
Speakers:
Phil Cyr, Senior Vice President, Precision Value & Health – Confirmed
Derek Hicks, Chief Business Officer, Intellia Therapeutics – Confirmed
Ann Lee, Ph.D., Chief Technical Officer, Prime Medicine – Confirmed
Bob Smith, Senior Vice President, Global Gene Therapy Business, Pfizer – Confirmed
Arthur Tzianabos, Ph.D., Venture Partner, 5AM Ventures – Confirmed
Event Timeslots (1)
Tuesday | October 10, 2023
-
brady